WYMM Tour: Melbourne
March 19 2025, 9:00 AM - 5:30 PM AEDT
Melbourne, Australia

WYMM Tour: Melbourne

Wednesday, 19th March 2025, 09:30 - 16:40 AEDT - Melbourne, Australia (time subject to change)

Generate ultra-rich data for answers with impact.

Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.​​

Join us on Wednesday, 19th March 2025, to hear from local experts who are breaking new ground in human genomics, using nanopore technology.​​​

What you're missing matters. Stay on top of what's next.​

Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.

Please note that this is an in-person event.

There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.

Agenda coming soon!

Register

Speakers

picture of Quentin Gouil

Shining light on the pathogenic D4Z4 macrosatellite (epi)genetics with nanopore sequencing

Quentin Gouil, Olivia Newton-John Cancer Research Institute

Dr Gouil is an NHMRC Emerging Leadership fellow and lab head at the Olivia Newton-John Cancer Resear...

picture of Lorey Smith

Investigating mRNA diversity in melanoma progression and therapy resistance

Lorey Smith, Peter MacCallum Cancer Centre

Dr Lorey Smith is a Mid-Career Victorian Cancer Agency Research fellow in Professor Grant McArthur’s...

picture of Marjan Naeini

Advancing Cancer Research with ONT: Improving Structural Variation and Methylation Detection

Marjan Naeini, Garvan Institute of Medical Research

Dr. Naeini is a postdoctoral researcher in the Genomic Technologies Group at the Garvan Institute of...

picture of Rodrigo Carlessi

Methylation-based ctDNA Detection with Nanopore Sequencing

Rodrigo Carlessi, Curtin Medical Research Institute

Dr Rodrigo Carlessi is a Senior Research Fellow and the leader of the Cancer Genomics Group within t...

picture of Matthew Loose

Matthew Loose, Deep Seq, School of Life Sciences, University of Nottingham

...

Jane Hawkey, Department of Infectious Diseases, School of Translational Medicine, Monash University and The Alfred Hospital

...